COVID-19 has evolved into a long-term population health problem that requires new types of diagnostics. Diagnostic developers, therefore, are called on to expand their developmental focus to include novel tests to predict severity and disease progression as COVID-19 transitions from a public health crisis to a manageable, endemic disease.

Nearly 300 FDA-authorized diagnostic tests are available now, but virtually all of them focus on those public health aspects of COVID-19, either detecting the presence of the virus or its antibodies.

Now some diagnostic developers are looking ahead to the time when COVID-19 is endemic throughout the population and most people are vaccinated.

From a public health perspective, COVID-19 will be treated like the seasonal flu.

Read More